Sakar Healthcare Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Sakar Healthcare Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
34.99% Fall from 52W High
-13.1
TTM PE Ratio
High in industry
57
Price to Book Ratio
Below industry Median
2.5
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-6.7
RSI
RSI is mid-range
48.1
MFI
MFI is mid-range
55.4

Sakar Healthcare Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Sakar Healthcare Ltd shareholding Pattern

Promoter
53.2%
Foreign Institutions
13.5%
Domestic Institutions
10.6%
Public
22.7%
Promoter
53.2%
Foreign Institutions
13.8%
Domestic Institutions
10.6%
Public
22.5%
Promoter
54.2%
Foreign Institutions
14%
Domestic Institutions
10.8%
Public
21%
Promoter
60.7%
Foreign Institutions
15.7%
Public
23.5%
Promoter
60.7%
Foreign Institutions
15.7%
Public
23.5%
Promoter
62.1%
Foreign Institutions
16.1%
Domestic Institutions
0.3%
Public
21.4%

Sakar Healthcare Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
326.40
10Day EMA
325.80
12Day EMA
326.30
20Day EMA
329.90
26Day EMA
332.80
50Day EMA
343.40
100Day EMA
355.00
200Day EMA
348.40
5Day SMA
326.40
10Day SMA
320.80
20Day SMA
330.50
30Day SMA
335.20
50Day SMA
345.90
100Day SMA
369.00
150Day SMA
376.50
200Day SMA
368.40
Delivery & Volume
Resistance & Support
327.73
Pivot
Resistance
First Resistance
337.17
Second Resistance
343.43
Third Resistance
352.87
Support
First Support
321.47
Second support
312.03
Third Support
305.77
Relative Strength Index
48.07
Money Flow Index
55.39
MACD
-6.48
MACD Signal
-7.91
Average True Range
14.21
Average Directional Index
11.11
Rate of Change (21)
-4.09
Rate of Change (125)
-11.80
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Ind-Swift Laboratories Ltd.
698.58
71.3
138.45
Nectar Lifesciences Ltd.
756.88
17.95
45.7
Albert David Ltd.
735.42
588
1607.9
Medicamen Biotech Ltd.
606.43
355.45
845
Valiant Laboratories Ltd.
636.59
129.3
214.95
Accent Microcell Ltd.
-
-
-

Sakar Healthcare Ltd Company background

Founded in: 2004
Managing director: Sanjay S Shah.
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022, the Company started commercialization with Oncology product post receiving WHO GMP certification.
Read More

Sakar Healthcare Ltd FAQs

The past 1-year return of Sakar Healthcare Ltd [SAKAR] share was 20.9. The Sakar Healthcare Ltd [SAKAR] share hit a 1-year low of Rs. 235.95 and a 1-year high of Rs. 479.

The market cap of Sakar Healthcare Ltd is Rs. 719.7 Cr. as of 6/14/2024 12:00:00 AM.

The PE ratios of Sakar Healthcare Ltd is 61.62 as of 6/14/2024 12:00:00 AM.

The PB ratios of Sakar Healthcare Ltd is 2.74 as of 6/14/2024 12:00:00 AM

You can easily buy Sakar Healthcare Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage